• Profile
Close

Would lipophilic statin therapy as a prognostic factor improve survival in patients with uterine cervical cancer?

International Journal of Gynecological Cancer Sep 16, 2017

Song MK, et al. - The objective of this study is to examine whether statin therapy as a prognostic factor would significantly predict survival in cervical cancer. The outcome of this study suggests that the continuous lipophilic statin therapy from the prediagnostic period of uterine cervical cancer could reflect favorable outcome, independently in the present study.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay